论文部分内容阅读
脑益嗪的药物作用类似罂粟碱,具有抗组胺和解除血管平滑肌痉挛等作用,并能改善脑及心脏血液循环和抑制变态反应。我科于1985年初开始用国产新药脑益嗪治疗慢性荨麻疹共计22例,治愈16例,显效3例,好转2例,无效1例。副作用较一般抗组胺药物轻微。一、临床资料 1.病例概况:22例慢性荨麻疹(男性12例,女性10例)。年龄最大72岁,最小20岁,平均年龄为39.3岁。
Cerebral yinzine similar to the role of papaverine drugs, with antihistamine and relieve vascular smooth muscle spasm role, and can improve brain and heart blood circulation and inhibit allergy. In early 1985, our department began to treat 22 cases of chronic urticaria with domestic new drug, cerebral yinzine, 16 cases were cured, 3 cases were markedly effective, 2 cases were improved, 1 case was ineffective. Side effects than the average antihistamine mild. First, the clinical data 1. Case overview: 22 cases of chronic urticaria (12 males and 10 females). The oldest is 72 years old and the youngest is 20 years old, with an average age of 39.3 years.